H.R. 2161 — Prescription Value Act

Summary

Prescription Value Act - Directs the Director of the Agency for Healthcare Research and Quality to: (1) collect scientific evidence regarding the relative clinical appropriateness and cost-effectiveness of prescription drugs frequently used by Medicare and Medicaid beneficiaries; (2) assess the validity and reliability of such evidence; and (3) identify areas of additional research needed to make an objective determination on the clinical appropriateness and cost-effectiveness of such drugs.

Full Text

Legislative Actions

2003-05-20
Introduced in House
2003-05-20
Introduced in House
2003-05-20
Referred to the House Committee on Energy and Commerce.
2003-06-02
Referred to the Subcommittee on Health.

Prescription Value Act

Sponsors

Subjects

Summary

Full Text

Legislative Actions

Ask about this bill